Mycosamine Orientation of Amphotericin B Controlling Interaction with Ergosterol: Sterol-Dependent Activity of Conformation-Restricted Derivatives with an Amino-Carbonyl Bridge
- 12 July 2005
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 127 (30) , 10667-10675
- https://doi.org/10.1021/ja051597r
Abstract
Amphotericin B (AmB 1) is known to assemble together and form an ion channel across biomembranes. The antibiotic consists of mycosamine and macrolactone moieties, whose relative geometry is speculated to be determinant for the drug's channel activity and sterol selectivity. To better understand the relationship between the amino-sugar orientation and drug's activity, we prepared conformation-restricted derivatives 2 − 4, in which the amino and carboxyl groups were bridged together with various lengths of alkyl chains. K+ influx assays across the lipid-bilayer membrane revealed that ergosterol selectivity was markedly different among derivatives; short-bridged derivative 2 almost lost the selectivity, while 3 showed higher ergosterol preference than AmB itself. Monte Carlo conformational analysis of 2 − 4 based on NOE-derived distances indicated that the amino-sugar moiety of 2 comes close to C41 because of the short bridge, whereas those of 3 and 4 are pointing outward. The mutual orientation of the amino-sugar moiety and macrolide ring is so rigid in derivatives 2 and 3 that these conformations should be unchanged upon complex formation in lipid membranes. These results strongly suggest that the large difference in sterol preference between derivatives 2 and 3 is ascribed to the different orientation of amino-sugar moieties. These findings allowed us to propose a simple model accounting for AmB−sterol interactions, in which hydrogen bonding between 2‘-OH of AmB and 3β-OH of ergosterol plays an important role.Keywords
This publication has 28 references indexed in Scilit:
- Dominant Formation of a Single-Length Channel by Amphotericin B in Dimyristoylphosphatidylcholine Membrane Evidenced by 13C−31P Rotational Echo Double ResonanceBiochemistry, 2004
- Low-mode conformational search elucidated: Application to C39H80 and flexible docking of 9-deazaguanine inhibitors into PNPJournal of Computational Chemistry, 1999
- Effect of the modifications of ionizable groups of amphotericin B on its ability to form complexes with sterols in hydroalcoholic mediaBiochimica et Biophysica Acta (BBA) - Biomembranes, 1995
- Macromodel—an integrated software system for modeling organic and bioorganic molecules using molecular mechanicsJournal of Computational Chemistry, 1990
- Amphotericin B: 30 Years of Clinical ExperienceClinical Infectious Diseases, 1990
- Amphotericin and model membranes. The effect of amphotericin B on cholesterol-containing systems as viewed by 2H-NMRBiochimica et Biophysica Acta (BBA) - Biomembranes, 1984
- Differences in the interaction of the polyene antibiotic amphotericin B with cholesterol- or ergosterol-containing phospholipid vesicles. A circular dichroism and permeability studyBiochemistry, 1983
- Effect of amphotericin B on cholesterol-containing liposomes of egg phosphatidylcholine and didocosenoyl phosphatidylcholine. A refinement of the model for the formation of pores by amphotericin B in membranesBiochimica et Biophysica Acta (BBA) - Biomembranes, 1978
- THE STRUCTURE AND FUNCTION OF AMPHOTERICIN B‐CHOLESTEROL PORES IN LIPID BILAYER MEMBRANES*Annals of the New York Academy of Sciences, 1974
- Polyene macrolide antibiotic amphotericin B. Crystal structure of the N-iodoacetyl derivativeJournal of the American Chemical Society, 1971